XML 29 R15.htm IDEA: XBRL DOCUMENT v3.25.1
Description of Business and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2025
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following is a summary of cash, cash equivalents and restricted cash at March 31, 2025 and December 31, 2024:

 

(in thousands)  March 31,
2025		   December 31,
2024		 
Cash and cash equivalents  $65,325   $72,904 
Restricted cash – long-term   327    324 
Cash, cash equivalents and restricted cash  $65,652   $73,228 
Schedule of Diluted Net Loss Per Share For the three months ended March 31, 2025 and 2024, the Company’s potentially dilutive shares, which include outstanding common stock options, restricted stock units and warrants, have not been included in the computation of diluted net loss per share as the result would have been anti-dilutive.
(in thousands)  March 31, 2025   March 31, 2024 
Stock Options   271    5,421 
Restricted Stock Units   300    305 
Warrants   7    1,439 
Total   578    7,165